The careful choice of nanoparticles as targets and in drug delivery routes enhances therapeutic efficacy in cancer.
Nanoparticle-Based Drug Delivery in Cancer
Treatment
discusses nanotechnological developments of interfering RNA-based nanoparticles, delivery vehicles, and validated therapeutic RNAi–molecular target interactions and explains the results of clinical and preclinical trials. The book also gives strategies for universal methods of constructing hybrid organic–inorganic nanomaterials that can be widely applied in the biomedical field.
Key Features:
Reviews recent advances of nanoparticle-mediated siRNA delivery systems and their application in clinical trials for cancer therapy
Focuses on material platforms that establish NPs and both localized and controlled gene silencing
Emphasizes the most promising systems for clinical application
Surveys progress in nanoparticle-based nanomedicine in cancer treatment
Describes the most advanced of the nonviral nanocarriers for delivery of oligonucleotides to malignant blood cancer cells
This book is a valuable resource for researchers, professors, and students researching drug delivery, gene carriers, cancer therapy, nanotechnology, and nanomaterials.